Publications for Andrea Lindgren (Koch)
Co-author map based on ISI articles 2007-
Publications mentioned in social media 1 times*
|Sverre Sörenson, Helena Fohlin, Andrea Lindgren, Magnus Lindskog, Bengt Bergman, Christer Sederholm, Lars Ek, Kristina Lamberg and Birgitta Clinchy|
Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy
European Journal of Cancer, 2013, 49(1), 115-120.
Web of Science® Times Cited: 1
|Andrea Koch, Bengt Bergman, Erik Holmberg, Christer Sederholm, Lars Ek, Jaroslaw Kosieradzki, Kristina Lamberg, Lars Thaning, Sven-Olof Ydreborg and Sverre Sörenson|
Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group
European Journal of Cancer, 2011, 47(10), 1546-1555.
Web of Science® Times Cited: 10
|Andrea Koch, Bertil Gustafsson, Helena Fohlin and Sverre Sörenson|
Cyclooxygenase-2 expression in lung cancer cells evaluated by immunocytochemistry
Diagnostic Cytopathology, 2011, 39(3), 188-193.
Web of Science® Times Cited: 4
|Andrea Koch, Helena Fohlin and Sverre Sörenson|
Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, 4(3), 326-32.
Web of Science® Times Cited: 29
|Andrea Koch, Sverre Sörenson, Asgeir Askeland and Tor Aasen|
Rapportering av yrkesrelatert lungekreft.
Lungeforum, 2003, 13, 12-16.
* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.